Skip to main content
Top
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Magnetic Resonance Imaging | Research

Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning

Authors: Jung-in Kim, Jong Min Park, Chang Heon Choi, Hyun Joon An, Yi-Jun Kim, Jin Ho Kim

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

Background

This study compared adaptive replanning and repositioning corrections based on soft-tissue matching for prostate cancer by using the magnetic resonance-guided radiation therapy (MRgRT) system.

Methods

A total of 19 patients with prostate cancer were selected retrospectively. Weekly magnetic resonance image (MRI) scans were acquired for 5 weeks for each patient to observe the anatomic changes during the treatment course. Initial intensity-modulated radiation therapy (IMRT) plans (iIMRT) were generated for each patient with 13 coplanar 60Co beams on a ViewRay™ system. Two techniques were applied: patient repositioning and replanning. For patient repositioning, one plan was created: soft-tissue (prostate) matching (Soft). The dose distribution was calculated for each MRI with the beam delivery parameters from the initial IMRT plan. The replanning technique was used to generate the Adaptive plan, which was the reoptimized plan for the weekly MRI. The dose-volumetric parameters of the planning target volume (PTV), bladder, and rectum were calculated for all plans. During the treatment course, the PTV, bladder, and rectum were evaluated for changes in volume and the effect on dosimetric parameters. The differences between the dose-volumetric parameters of the plans were examined through the Wilcoxon test. The initial plan was used as a baseline to compare the differences.

Results

The Adaptive plan showed better target coverage during the treatment period, but the change was not significant in the Soft plan. There were significant differences in D98%, D95%, and D2% in PTV between the Soft and Adaptive plans (p < 0.05) except for Dmean. There was no significant change in Dmax and Dmean as the treatment progressed with all plans. All indices for the Adaptive plan stayed the same compared to those of iIMRT during the treatment course. There were significant differences in D15%, D25%, D35%, and D50% in the bladder between the Soft and Adaptive plans. The Adaptive plan showed the worse dose sparing than the Soft plan for the bladder according to each dosimetric index. In contrast to the bladder, the Adaptive plan achieved better sparing than the Soft plan during the treatment course. The significant differences were only observed in D15% and D35% between the Soft and Adaptive plans (p < 0.05).

Conclusions

Patient repositioning based on the target volume (Soft plan) can relatively retain the target coverage for patients and the OARs remain at a clinically tolerance level during the treatment course. The Adaptive plan did not clinically improve for the dose delivered to OARs, it kept the dose delivered to the target volume constant. However, the Adaptive plan is beneficial when the organ positions and volumes change considerable during treatment.
Literature
1.
go back to reference Daoud MA, Aboelnaga EM, Alashry MS, Fathy S, Aletreby MA. Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. Onco Targets Ther. 2017;10:4981–8.CrossRef Daoud MA, Aboelnaga EM, Alashry MS, Fathy S, Aletreby MA. Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. Onco Targets Ther. 2017;10:4981–8.CrossRef
2.
go back to reference Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012;83:1169–78.CrossRef Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012;83:1169–78.CrossRef
3.
go back to reference Pasler M, Georg D, Wirtz H, Lutterbach J. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol. 2011;187:792–8.CrossRef Pasler M, Georg D, Wirtz H, Lutterbach J. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol. 2011;187:792–8.CrossRef
4.
go back to reference Davidson MT, Blake SJ, Batchelar DL, Cheung P, Mah K. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys. 2011;80:1550–8.CrossRef Davidson MT, Blake SJ, Batchelar DL, Cheung P, Mah K. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys. 2011;80:1550–8.CrossRef
5.
go back to reference Tsai CL, Wu JK, Chao HL, Tsai YC, Cheng JC. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim. 2011;36:264–71.CrossRef Tsai CL, Wu JK, Chao HL, Tsai YC, Cheng JC. Treatment and dosimetric advantages between VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim. 2011;36:264–71.CrossRef
6.
go back to reference Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93:226–33.CrossRef Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93:226–33.CrossRef
7.
go back to reference Guckenberger M, Lawrenz I, Flentje M. Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. Strahlenther Onkol. 2014;190:48–53.CrossRef Guckenberger M, Lawrenz I, Flentje M. Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. Strahlenther Onkol. 2014;190:48–53.CrossRef
8.
go back to reference Muller AC, Lutjens J, Alber M, Eckert F, Bamberg M, Schilling D, et al. Toxicity and outcome of pelvic IMRT for node-positive prostate cancer. Strahlenther Onkol. 2012;188:982–9.CrossRef Muller AC, Lutjens J, Alber M, Eckert F, Bamberg M, Schilling D, et al. Toxicity and outcome of pelvic IMRT for node-positive prostate cancer. Strahlenther Onkol. 2012;188:982–9.CrossRef
9.
go back to reference Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, et al. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008;71:813–20.CrossRef Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, et al. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008;71:813–20.CrossRef
10.
go back to reference Little DJ, Dong L, Levy LB, Chandra A, Kuban DA. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys. 2003;56:1218–24.CrossRef Little DJ, Dong L, Levy LB, Chandra A, Kuban DA. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys. 2003;56:1218–24.CrossRef
11.
go back to reference Gill SK, Reddy K, Campbell N, Chen C, Pearson D. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins. J Appl Clin Med Phys. 2015;16:252–62.CrossRef Gill SK, Reddy K, Campbell N, Chen C, Pearson D. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins. J Appl Clin Med Phys. 2015;16:252–62.CrossRef
12.
go back to reference Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2009;74:388–91.CrossRef Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2009;74:388–91.CrossRef
13.
go back to reference Sanguineti G, Endres EJ, Parker BC, Bicquart C, Little M, Chen G, et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol. 2008;47:301–10.CrossRef Sanguineti G, Endres EJ, Parker BC, Bicquart C, Little M, Chen G, et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol. 2008;47:301–10.CrossRef
14.
go back to reference Groher M, Kopp P, Drerup M, Deutschmann H, Sedlmayer F, Wolf F. An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer. Strahlenther Onkol. 2017;193:750–5.CrossRef Groher M, Kopp P, Drerup M, Deutschmann H, Sedlmayer F, Wolf F. An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer. Strahlenther Onkol. 2017;193:750–5.CrossRef
15.
go back to reference Mayyas E, Kim J, Kumar S, Liu C, Wen N, Movsas B, et al. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate. Med Phys. 2014;41:091709.CrossRef Mayyas E, Kim J, Kumar S, Liu C, Wen N, Movsas B, et al. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate. Med Phys. 2014;41:091709.CrossRef
16.
go back to reference Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, et al. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. Am J Clin Oncol. 2011;34:16–21.CrossRef Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, et al. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. Am J Clin Oncol. 2011;34:16–21.CrossRef
17.
go back to reference Barney BM, Lee RJ, Handrahan D, Welsh KT, Cook JT, Sause WT. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys. 2011;80:301–5.CrossRef Barney BM, Lee RJ, Handrahan D, Welsh KT, Cook JT, Sause WT. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys. 2011;80:301–5.CrossRef
18.
go back to reference Thongphiew D, Wu QJ, Lee WR, Chankong V, Yoo S, McMahon R, et al. Comparison of online IGRT techniques for prostate IMRT treatment: adaptive vs repositioning correction. Med Phys. 2009;36:1651–62.CrossRef Thongphiew D, Wu QJ, Lee WR, Chankong V, Yoo S, McMahon R, et al. Comparison of online IGRT techniques for prostate IMRT treatment: adaptive vs repositioning correction. Med Phys. 2009;36:1651–62.CrossRef
19.
go back to reference Nairz O, Merz F, Deutschmann H, Kopp P, Scholler H, Zehentmayr F, et al. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol. 2008;184:663–7.CrossRef Nairz O, Merz F, Deutschmann H, Kopp P, Scholler H, Zehentmayr F, et al. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol. 2008;184:663–7.CrossRef
20.
go back to reference Song WY, Schaly B, Bauman G, Battista JJ, Van Dyk J. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. Int J Radiat Oncol Biol Phys. 2006;64:289–300.CrossRef Song WY, Schaly B, Bauman G, Battista JJ, Van Dyk J. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. Int J Radiat Oncol Biol Phys. 2006;64:289–300.CrossRef
21.
go back to reference Delpon G, Llagostera C, Le Blanc M, Rio E, Supiot S, Mahe MA, et al. Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy). Cancer Radiother. 2009;13:399–407.CrossRef Delpon G, Llagostera C, Le Blanc M, Rio E, Supiot S, Mahe MA, et al. Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy). Cancer Radiother. 2009;13:399–407.CrossRef
22.
go back to reference Miszczyk L, Leszczynski W, Szczepanik K, Majewski W. Comparison of two image guided radiation therapy (IGRT) methods used for prostate cancer patients--CBCT and 2D-2D kV. Przegl Lek. 2008;65:315–20.PubMed Miszczyk L, Leszczynski W, Szczepanik K, Majewski W. Comparison of two image guided radiation therapy (IGRT) methods used for prostate cancer patients--CBCT and 2D-2D kV. Przegl Lek. 2008;65:315–20.PubMed
23.
go back to reference O'Neill AG, Jain S, Hounsell AR, O'Sullivan JM. Fiducial marker guided prostate radiotherapy: a review. Br J Radiol. 2016;89:20160296.CrossRef O'Neill AG, Jain S, Hounsell AR, O'Sullivan JM. Fiducial marker guided prostate radiotherapy: a review. Br J Radiol. 2016;89:20160296.CrossRef
24.
go back to reference Li XA, Wu Q, Orton CG. Point/counterpoint. Online adaptive planning for prostate cancer radiotherapy is necessary and ready now. Med Phys. 2014;41:080601.CrossRef Li XA, Wu Q, Orton CG. Point/counterpoint. Online adaptive planning for prostate cancer radiotherapy is necessary and ready now. Med Phys. 2014;41:080601.CrossRef
25.
go back to reference Thornqvist S, Hysing LB, Zolnay AG, Sohn M, Hoogeman MS, Muren LP, et al. Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model. Acta Oncol. 2013;52:1423–9.CrossRef Thornqvist S, Hysing LB, Zolnay AG, Sohn M, Hoogeman MS, Muren LP, et al. Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model. Acta Oncol. 2013;52:1423–9.CrossRef
26.
go back to reference Haverkort MA, van de Kamer JB, Pieters BR, Koning CC, van Herk M, van Tienhoven G. Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit? Radiother Oncol. 2012;105:203–6.CrossRef Haverkort MA, van de Kamer JB, Pieters BR, Koning CC, van Herk M, van Tienhoven G. Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit? Radiother Oncol. 2012;105:203–6.CrossRef
27.
go back to reference Lei Y, Wu Q. A hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapy. Phys Med Biol. 2010;55:2221–34.CrossRef Lei Y, Wu Q. A hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapy. Phys Med Biol. 2010;55:2221–34.CrossRef
28.
go back to reference Hilman S, Smith R, Masson S, Coomber H, Bahl A, Challapalli A, et al. Implementation of a Daily Transperineal Ultrasound System as Image-guided Radiotherapy for Prostate Cancer. Clin Oncol (R Coll Radiol). 2017;29:e49.CrossRef Hilman S, Smith R, Masson S, Coomber H, Bahl A, Challapalli A, et al. Implementation of a Daily Transperineal Ultrasound System as Image-guided Radiotherapy for Prostate Cancer. Clin Oncol (R Coll Radiol). 2017;29:e49.CrossRef
29.
go back to reference Maund IF, Benson RJ, Fairfoul J, Cook J, Huddart R, Poynter A. Image-guided radiotherapy of the prostate using daily CBCT: the feasibility and likely benefit of implementing a margin reduction. Br J Radiol. 2014;87:20140459.CrossRef Maund IF, Benson RJ, Fairfoul J, Cook J, Huddart R, Poynter A. Image-guided radiotherapy of the prostate using daily CBCT: the feasibility and likely benefit of implementing a margin reduction. Br J Radiol. 2014;87:20140459.CrossRef
30.
go back to reference Zhang YD, Wu CJ, Bao ML, Li H, Yan X, Liu XS, et al. New RESOLVE-based diffusional kurtosis imaging in MRI-visible prostate Cancer: effect of reduced b value on image quality and diagnostic effectiveness. AJR Am J Roentgenol. 2016;207:330–8.CrossRef Zhang YD, Wu CJ, Bao ML, Li H, Yan X, Liu XS, et al. New RESOLVE-based diffusional kurtosis imaging in MRI-visible prostate Cancer: effect of reduced b value on image quality and diagnostic effectiveness. AJR Am J Roentgenol. 2016;207:330–8.CrossRef
31.
go back to reference Barth BK, Cornelius A, Nanz D, Eberli D, Donati OF. Comparison of image quality and patient discomfort in prostate MRI: pelvic phased array coil vs. endorectal coil. Abdom Radiol (NY). 2016;41:2218–26.CrossRef Barth BK, Cornelius A, Nanz D, Eberli D, Donati OF. Comparison of image quality and patient discomfort in prostate MRI: pelvic phased array coil vs. endorectal coil. Abdom Radiol (NY). 2016;41:2218–26.CrossRef
32.
go back to reference Lutgendorf-Caucig C, Fotina I, Stock M, Potter R, Goldner G, Georg D. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol. 2011;98:154–61.CrossRef Lutgendorf-Caucig C, Fotina I, Stock M, Potter R, Goldner G, Georg D. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol. 2011;98:154–61.CrossRef
33.
go back to reference Tenhunen M, Korhonen J, Kapanen M, Seppala T, Koivula L, Collan J, et al. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol. 2018;57:902–7.CrossRef Tenhunen M, Korhonen J, Kapanen M, Seppala T, Koivula L, Collan J, et al. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol. 2018;57:902–7.CrossRef
34.
go back to reference Ghose S, Mitra J, Rivest-Henault D, Fazlollahi A, Stanwell P, Pichler P, et al. MRI-alone radiation therapy planning for prostate cancer: automatic fiducial marker detection. Med Phys. 2016;43:2218.CrossRef Ghose S, Mitra J, Rivest-Henault D, Fazlollahi A, Stanwell P, Pichler P, et al. MRI-alone radiation therapy planning for prostate cancer: automatic fiducial marker detection. Med Phys. 2016;43:2218.CrossRef
35.
go back to reference Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M 3rd, Jung AJ, Carroll PR, et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012;82:e787–93.CrossRef Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M 3rd, Jung AJ, Carroll PR, et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012;82:e787–93.CrossRef
36.
go back to reference Pasquier D, Lartigau E. MRI prostate radiation therapy planning: when the patient distorts his own image (regarding Lambert et al., Radiother Oncol 2011; 98: 330-334). Radiother Oncol. 2012;102:163.CrossRef Pasquier D, Lartigau E. MRI prostate radiation therapy planning: when the patient distorts his own image (regarding Lambert et al., Radiother Oncol 2011; 98: 330-334). Radiother Oncol. 2012;102:163.CrossRef
37.
go back to reference Mutic S, Dempsey JF. The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol. 2014;24:196–9.CrossRef Mutic S, Dempsey JF. The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol. 2014;24:196–9.CrossRef
38.
go back to reference Iraha Y, Murayama S, Kamiya A, Iraha S, Ogawa K. Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy. Anticancer Res. 2012;32:4467–71.PubMed Iraha Y, Murayama S, Kamiya A, Iraha S, Ogawa K. Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy. Anticancer Res. 2012;32:4467–71.PubMed
39.
go back to reference Lambert J, Greer PB, Menk F, Patterson J, Parker J, Dahl K, et al. MRI-guided prostate radiation therapy planning: investigation of dosimetric accuracy of MRI-based dose planning. Radiother Oncol. 2011;98:330–4.CrossRef Lambert J, Greer PB, Menk F, Patterson J, Parker J, Dahl K, et al. MRI-guided prostate radiation therapy planning: investigation of dosimetric accuracy of MRI-based dose planning. Radiother Oncol. 2011;98:330–4.CrossRef
40.
go back to reference Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol. 2002;75:603–7.CrossRef Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol. 2002;75:603–7.CrossRef
41.
go back to reference Marden FA, Wippold FJ 2nd, Perry A. Fast magnetic resonance imaging in steady-state precession (true FISP) in the prenatal diagnosis of a congenital brain teratoma. J Comput Assist Tomogr. 2003;27:427–30.CrossRef Marden FA, Wippold FJ 2nd, Perry A. Fast magnetic resonance imaging in steady-state precession (true FISP) in the prenatal diagnosis of a congenital brain teratoma. J Comput Assist Tomogr. 2003;27:427–30.CrossRef
42.
go back to reference Hodapp N. The ICRU report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188:97–9.CrossRef Hodapp N. The ICRU report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188:97–9.CrossRef
43.
go back to reference Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105(Suppl):194–201.CrossRef Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105(Suppl):194–201.CrossRef
44.
go back to reference Son CH, Melotek JM, Liao C, Hubert G, Pelizzari CA, Eggener SE, et al. Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol. 2016;6:e179–e85.CrossRef Son CH, Melotek JM, Liao C, Hubert G, Pelizzari CA, Eggener SE, et al. Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol. 2016;6:e179–e85.CrossRef
45.
go back to reference Frizzell B, Lovato J, Foster J, Towers A, Lucas J, Able C. Impact of bladder volume on radiation dose to the rectum in the definitive treatment of prostate cancer. J Community Support Oncol. 2015;13:288–91.CrossRef Frizzell B, Lovato J, Foster J, Towers A, Lucas J, Able C. Impact of bladder volume on radiation dose to the rectum in the definitive treatment of prostate cancer. J Community Support Oncol. 2015;13:288–91.CrossRef
46.
go back to reference Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76:S116–22.CrossRef Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76:S116–22.CrossRef
47.
go back to reference Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, et al. Magnetic resonance imaging-guided adaptive radiation therapy: a "game changer" for prostate treatment? Int J Radiat Oncol Biol Phys. 2018;100:361–73.CrossRef Pathmanathan AU, van As NJ, Kerkmeijer LGW, Christodouleas J, Lawton CAF, Vesprini D, et al. Magnetic resonance imaging-guided adaptive radiation therapy: a "game changer" for prostate treatment? Int J Radiat Oncol Biol Phys. 2018;100:361–73.CrossRef
48.
go back to reference McPartlin AJ, Li XA, Kershaw LE, Heide U, Kerkmeijer L, Lawton C, et al. MRI-guided prostate adaptive radiotherapy - a systematic review. Radiother Oncol. 2016;119:371–80.CrossRef McPartlin AJ, Li XA, Kershaw LE, Heide U, Kerkmeijer L, Lawton C, et al. MRI-guided prostate adaptive radiotherapy - a systematic review. Radiother Oncol. 2016;119:371–80.CrossRef
49.
go back to reference Park JM, Wu HG, Kim HJ, Choi CH, Kim JI. Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR. Radiat Oncol. 2019;14:105.CrossRef Park JM, Wu HG, Kim HJ, Choi CH, Kim JI. Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR. Radiat Oncol. 2019;14:105.CrossRef
50.
go back to reference Winkel D, Bol GH, Kiekebosch IH, Van Asselen B, Kroon PS, Jurgenliemk-Schulz IM, et al. Evaluation of Online Plan Adaptation Strategies for the 1.5T MR-linac Based on "First-In-Man" Treatments. Cureus. 2018;10:e2431.PubMedPubMedCentral Winkel D, Bol GH, Kiekebosch IH, Van Asselen B, Kroon PS, Jurgenliemk-Schulz IM, et al. Evaluation of Online Plan Adaptation Strategies for the 1.5T MR-linac Based on "First-In-Man" Treatments. Cureus. 2018;10:e2431.PubMedPubMedCentral
51.
go back to reference Polat B, Guenther I, Wilbert J, Goebel J, Sweeney RA, Flentje M, et al. Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol. 2008;184:668–73.CrossRef Polat B, Guenther I, Wilbert J, Goebel J, Sweeney RA, Flentje M, et al. Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol. 2008;184:668–73.CrossRef
Metadata
Title
Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning
Authors
Jung-in Kim
Jong Min Park
Chang Heon Choi
Hyun Joon An
Yi-Jun Kim
Jin Ho Kim
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1349-2

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue